- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (68)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (234)
- Breast Cancer (714)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (158)
- Colon Cancer (166)
- Colorectal Cancer (106)
- Endocrine Tumor (4)
- Esophageal Cancer (40)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Kidney Cancer (124)
- Leukemia (352)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (286)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (102)
- Myelodysplastic Syndrome (64)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (102)
- Ovarian Cancer (172)
- Pancreatic Cancer (172)
- Parathyroid Disease (2)
- Penile Cancer (16)
- Pituitary Tumor (6)
- Prostate Cancer (146)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (54)
- Spinal Tumor (12)
- Stomach Cancer (58)
- Testicular Cancer (28)
- Throat Cancer (92)
- Thymoma (6)
- Thyroid Cancer (96)
- Tonsil Cancer (32)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (8)
- Advance Directives (4)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (622)
- Complementary Integrative Medicine (20)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (220)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (12)
- Hereditary Cancer Syndromes (126)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (114)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (858)
- Research (402)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (598)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (406)
- Survivorship (320)
- Symptoms (178)
- Treatment (1756)
Six MD Anderson researchers chosen for AAAS
BY Lany Kimmons
2 minute read | Published December 13, 2017
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on December 13, 2017
In recognition of their contributions to basic, translational, and clinical research, six faculty members from MD Anderson Cancer Center have been named Fellows of the American Association for the Advancement of Science (AAAS). Election as a Fellow, a tradition that began in 1874, is an honor bestowed upon AAAS members by their peers. MD Anderson's faculty now includes 46 AAAS Fellows.
MD Anderson's newly elected AAAS Fellows are:
John Heymach, M.D., Ph.D., chair of Thoracic Head and Neck Medical Oncology, honored for identifying new therapeutic targets, biomarkers, mechanisms of drug resistance and treatment paradigms that have advanced the treatment of lung cancer worldwide.
Kelly Hunt, M.D., chair of Breast Surgical Oncology, honored for practice-changing breast cancer research involving sentinel lymph node biopsy, breast conservation, novel surgical staging systems, contralateral mastectomy, skin-sparing mastectomy and quality outcome measures.
Dimitrios Kontoyiannis, M.D., Ph.D., professor of Infectious Diseases, honored for contributions to medical/translational mycology through advances in antifungal pharmacology, study-host defenses against fungi, novel diagnostics, clinical trials, professional service and life-saving patient care.
Frederick Lang, M.D., professor of Neurosurgery, honored for contributions to the field of cancer biotherapeutics, particularly for developing and translating gene, adenoviral and stem cell therapies in the treatment of brain tumors.
Zhimin (James) Lu, M.D., Ph.D., professor of Neuro-Oncology, honored for milestone discoveries that elucidated mechanisms of the Warburg effect, demonstrated protein kinase activity of metabolic enzymes and revealed non-metabolic functions of metabolic enzymes in tumorigenesis.
Shao-Cong Sun, Ph.D., professor of Immunology, honored for his contributions to the understanding of NF-kB signaling pathways and the regulation of immune responses and inflammatory diseases by protein ubiquitination.
![Clockwise from top left: John Heymach, M.D., Ph.D., Kelly Hunt, M.D., Dimitrios Kontoyiannis, M.D., Ph.D., Frederick Lang, M.D., Zhimin (James) Lu, M.D., Ph.D., and Shao-Cong Sun, Ph.D., have been named Fellows of the American Association for the Advancement of Science.](/content/mda/en/publications/cancer-frontline/2017/12/six-md-anderson-researchers-chosen-for-aaas/jcr:content/blog/adaptiveimage.resize.278.0.medium.jpg/1513192005614.jpg)